DDX41 and acute myeloid leukemia: Another study among 3132 unrelated adult patients with myeloid malignancies identified 28 individuals (20/28 male) with germline DDX41 variants diagnosed with AML described chronic clinical trajectories (mean duration 11.2 months) during which patients with cytopenias were monitored before AML onset.